Atopic Dermatitis Drugs Market Size, Share & Trends Report

Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report By Drug Class (Biologics, PDE4 Inhibitors, Corticosteroids, Calcineurin Inhibitors), By Route Of Administration (Topical, Injectable, Oral), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-2-68038-546-5
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Market Segmentation

  • Atopic Dermatitis Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
    • Corticosteroids
    • Calcineurin Inhibitors
    • PDE4 Inhibitors
    • Biologics
    • Others
  • Atopic Dermatitis Drugs Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
    • Topical
    • Injectable
    • Oral
  • Atopic Dermatitis Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
        • Corticosteroids
        • Calcineurin Inhibitors
        • PDE4 Inhibitors
        • Biologics
        • Others
      • North America Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
        • Topical
        • Injectable
        • Oral
      • U.S.
        • U.S. Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • U.S. Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Canada
        • Canada Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Canada Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
    • Europe
      • Europe Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
        • Corticosteroids
        • Calcineurin Inhibitors
        • PDE4 Inhibitors
        • Biologics
        • Others
      • Europe Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
        • Topical
        • Injectable
        • Oral
      • UK
        • UK Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • UK Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Germany
        • Germany Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Germany Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • France
        • France Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • France Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Italy
        • Italy Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Italy Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Spain
        • Spain Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Spain Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Sweden
        • Sweden Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Sweden Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Norway
        • Norway Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Norway Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Denmark
        • Denmark Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Denmark Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
    • Asia Pacific
      • Asia Pacific Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
        • Corticosteroids
        • Calcineurin Inhibitors
        • PDE4 Inhibitors
        • Biologics
        • Others
      • Asia Pacific Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
        • Topical
        • Injectable
        • Oral
      • Japan
        • Japan Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Japan Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • China
        • China Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • China Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • India
        • India Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • India Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Australia
        • Australia Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Australia Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Thailand
        • Thailand Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Thailand Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • South Korea
        • South Korea Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • South Korea Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
    • Latin America
      • Latin America Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
        • Corticosteroids
        • Calcineurin Inhibitors
        • PDE4 Inhibitors
        • Biologics
        • Others
      • Latin America Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
        • Topical
        • Injectable
        • Oral
      • Brazil
        • Brazil Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Brazil Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Mexico
        • Mexico Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Mexico Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Argentina
        • Argentina Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Argentina Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
    • Middle East and Africa
      • Middle East and Africa Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
        • Corticosteroids
        • Calcineurin Inhibitors
        • PDE4 Inhibitors
        • Biologics
        • Others
      • Middle East and Africa Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
        • Topical
        • Injectable
        • Oral
      • South Africa
        • South Africa Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • South Africa Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Saudi Arabia
        • Saudi Arabia Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Saudi Arabia Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • UAE
        • UAE Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • UAE Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral
      • Kuwait
        • Kuwait Atopic Dermatitis Drugs Market, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
          • Corticosteroids
          • Calcineurin Inhibitors
          • PDE4 Inhibitors
          • Biologics
          • Others
        • Kuwait Atopic Dermatitis Drugs Market, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Topical
          • Injectable
          • Oral

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon